TEMPLATE DESIGN © 2008 www.PosterPresentations.com All PET scans were processed to uniform resolution as implemented by ADNI (Joshi, 2009) to minimize.

Slides:



Advertisements
Similar presentations
ADNI PiB Amyloid Imaging Chet Mathis University of Pittsburgh.
Advertisements

Discuss the use of technology in investigating cognitive processes
PRACTICE PARAMETER: RISK OF DRIVING AND ALZHEIMER ’ S DISEASE (AN EVIDENCE-BASED REVIEW) Richard M. Dubinsky, MD; Anthony C. Stein, PhD; and Kelly Lyons,
Disclosures/Conflicts Consulting: GE Healthcare Bayer Abbott Elan/Janssen Synarc Genentech Merck.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
CSF sulfatide is decreased in individuals with incipient dementia Xianlin Han, PhD, Anne M. Fagan, PhD, Hua Cheng, MS, John C. Morris, MD, Chengjie Xiong,
© 2014 Direct One Communications, Inc. All rights reserved. 1 New Insights into the Basic Mechanisms, Diagnosis, and Staging of Epilepsy Nicole Odom, MD.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Alzheimer’s Disease Neuroimaging Initiative Neuropathology Core John C. Morris, MD Nigel J. Cairns, PhD, FRCPath Erin Franklin, MS Presented by: Beau Ances,
Comparison of MRI Perfusion and PET-CT in Differentiating Brain Tumor Progression from Radiation Injury after Cranial Irradiation T. Jonathan Yang, M.D.
Mapping the correlations between CSF Abeta and tau and hippocampal atrophy in 282 ADNI subjects Liana G. Apostolova, Amity E. Green, Kristy S. Hwang, Jonathan.
Susceptibility Induced Loss of Signal: Comparing PET and fMRI on a Semantic Task Devlin et al. (in press)
Quantitative analysis of radiologic images: Image segmentation and registration, statistical atlases Christos Davatzikos, Ph.D. Professor of Radiology.
How To Improve Memory Performance and Keep Your Brain Young Gary W. Small, MD Parlow-Solomon Professor on Aging Professor of Psychiatry & Biobehavioral.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar.
Neural systems supporting the preparatory control of emotional responses Tor D. Wager, Brent L. Hughes, Matthew L. Davidson, Melissa Brandon, and Kevin.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
Dr Hussein Farghaly PSMMC
Jeremy R. Gray, Christopher F. Chabris and Todd S. Braver Elaine Chan Neural mechanisms of general fluid intelligence.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
References: [1]S.M. Smith et al. (2004) Advances in functional and structural MR image analysis and implementation in FSL. Neuroimage 23: [2]S.M.
Brain Metabolites in Patients with Asymptomatic Versus Symptomatic HIV-associated neurocognitive disorder: A 7 Tesla MR Spectroscopy Study Mohamed MA,
Our group recently reported that cerebral cortical development, specifically within aspects of vmPFC, is related to anxious/depressed problems in typically.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
Neuroimage Analysis Center An NCRR National Resource Center Time Series MRI Core Analysis, Modeling - toward Dynamic Surrogates.
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
PET Count  Word Frequency effects (coefficients) were reliably related to activation in both the striate and ITG for older adults only.  For older adults,
Kimiko Domoto-Reilly, MD Cognitive / Behavioral Neurology Fellow Massachusetts General Hospital & Brigham and Women’s Hospital.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
All Hands Meeting 2004 Clinician’s Requirements for HID Query and Statistics Interface Christine Fennema-Notestine, Ph.D. David Kennedy, Ph.D.
UC Davis Alzheimer’s Disease Center The Residual Approach to Measuring Cognitive Reserve in Aging and Dementia Bruce Reed & Dan Mungas University of California,
Advanced brain imaging and neurodegenerative disorders. Dott.ssa Ingrid Inches.
Adeline SL Ng, Amanda RJ Ng, Ivane Chew, Nagaendran Kandiah Department of Neurology, National Neuroscience Institute, Singapore APOE4 status modulates.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of Short- term conversion to AD: Results from ADNI Xuejiao.
Introduction  Recent neuroimaging studies of memory retrieval have reported the activation of a medial and left – lateralised memory network that includes.
A Novel Assessment Tool for Alzheimer's and Frontotemporal Dementias Jeanyung Chey 1,2, Hyun Song 2, Jungsuh Suk 1, & Minue J. Kim 3 The Proportional Reasoning.
ABSTRACT Figure 3. Results from two ANOVAs (HV > 0, MDD > 0) and a flexible factorial design (HV vs. MDD) in the unpleasant > neutral contrast are shown.
INFLUENCE OF FRACTIONAL ANISOTROPY THRESHOLD FOR TRACT BASED DIFFUSION TENSOR ANALYSIS OF UNCINATE FASCICLES IN ALZHEIMER DISEASE Toshiaki Taoka, Toshiaki.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Intranasal Insulin Therapy for Alzheimer Disease and.
Value of cerebrospinal fluid visinin-like protein-1 (VILIP-1) for prediction of mild cognitive impairment progression to Alzheimer's disease  Mirjana Babić.
Metabolic Syndrome and Progression of Mild Cognitive Impairment
31 Speaker: Hanna Lu (PhD Candidate of Medical Sciences, CUHK)
Rosa Maria Moresco University of Milan Bicocca
Manuela Tondelli, Gordon K. Wilcock, Paolo Nichelli, Celeste A
The relationship between Lifestyle Factors and Neurodegeneration in Midlife as expressed on fMRI: a Systematic Review Protocol Hinesh Topiwala,* Graciela.
Blood eosinophils as a biomarker in alpha 1 antitrypsin deficiency
Imaging AD Progression Amyloid Imaging Agents.
PPMI in the Medical Literature
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Cognition And Neocortical Volume After Stroke
Probing the Biology of Alzheimer's Disease in Mice
Volume 63, Issue 2, Pages (July 2009)
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Disruption of Large-Scale Brain Systems in Advanced Aging
Chris Hyde Exeter Test Group.
Network hubs in the human brain
Yoni K. Ashar, Jessica R. Andrews-Hanna, Sona Dimidjian, Tor D. Wager 
Biomarker Modeling of Alzheimer’s Disease
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability.
Clinical Concepts Emerging from fMRI Functional Connectomics
Volume 63, Issue 2, Pages (July 2009)
Presentation transcript:

TEMPLATE DESIGN © All PET scans were processed to uniform resolution as implemented by ADNI (Joshi, 2009) to minimize differences across scanner types. Automated ROI Method. PET scans were spatially normalized to a custom PET template using a fully reversible transform; this was applied to a set of template ROIs optimized for elderly, neurodegenerative populations, which upon reverse transformation were superimposed onto the subject’s native scan to sample without distortion from warping or smoothing of the original image. Univariate and multivariate analyses were performed whereby subjects including completely independent test cases were classified according to Mahalanobis distances from group centroids (Statistica, StatSoft, OK). Voxel Based Multivariate Analysis. We then applied NPAIRS (Non- parametric, Prediction, Activation, Influence, Re-Sampling) software (Strother et al, 2002; Zheng et al, 2009) to a subset of 24 NL, 24 AD, and 25 FTD subjects. NPAIRS combines a canonical variates (CV) training model with split-half re-sampling to identify the patterns differentiating groups (NL, AD, FTD). Metrics of pattern contribution to total variance, reproducibility, predictive power, subject ranking (CV score(s) and subject influence were produced. New subjects were then scored against classifier CVs. The NPAIRS classification of NL, AD, and FTD yielded 2 canonical variables (Figure 1) and corresponding eigenimages (Figures 2, 3). Regional cerebral glucose metabolism provides a sensitive and specific marker of AD, FTD and MCI, and correlates with CSF Abeta42 level decline in cognitively normal subjects Dawn Matthews, MS 1, Randolph Andrews, MS 1, Janine Diehl-Schmid, MD 2, Jordan Grafman, PhD 3, Lisa Mosconi, PhD 4, Mony J de Leon, PhD 4, and ADNI 1 Abiant, Inc., Grayslake, IL, 2 Technische Universität München, Munich, Germany, 3 National Institutes of Neurological Disorders and Stroke, Bethesda, MD, 4 New York University School of Medicine, NY Background References Li Y et al (2008) Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 35(12): Mosconi L et al (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med. Mar;49(3): Mosconi L et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology. Jun 14:64(11): Strother SC et al (2002) The quantitative evaluation of functional neuroimaging experiments: the NPAIRS data analysis framework. Neuroimage. Apr;15(4): Zhang J et al (2009) Evaluation and optimization of fMRI single-subject processing pipelines with NPAIRS and second-level CVA. Magn Reson Imaging. Feb;27(2): Measurement of regional cerebral glucose metabolism (rCMglc) using PET imaging has been demonstrated to detect and differentiate Normals (NL), MCI, AD, and frontotemporal dementia (FTD) subjects from multiple academic sites (Mosconi et al, 2008). Improved classification accuracies resulted from incorporation of hippocampal rCmglc measures into the analysis, enabled through a novel automated ROI method (Mosconi et al, 2005; Li et al, 2008). Adoption of PET imaging in the clinical setting requires demonstration across a broad range of sites. Approaches that can resolve the complexity and frequent overlap in regional rCMglc effects of these disease states may further increase accuracy and allow extension to disease subtypes. An understanding of the relationship between rCMglc levels and clinical progression within these heterogeneous categories would add further value. Finally, biomarkers of AD-related amyloid burden and Abeta42 levels have made it possible to explore the temporal relationship between rCMglc changes and pre-symptomatic markers of AD pathology. Together, these advances would enhance the value of PET imaging as an informative, practical diagnostic tool. Objectives We analyzed 33 NL, 58 MCI, and 34 AD subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database and 25 subjects diagnosed with frontal/behavioral variant FTD (5 autopsy confirmed) from two additional sites (Technische Universität München, NINDS). Table 1: Demographic and cognitive characteristics at baseline Dawn C. Matthews, Abiant, Inc. 480 West Center Street, Suite 202 Grayslake, Illinois U.S.A. Tel: Website: Methods Our objectives were to: Measure disease classification accuracies using these methods in a broader population, toward practical clinical application Evaluate the benefit of combined region of interest (ROI) analysis and a multivariate pattern classification approach Evaluate the relationship between rCMglc and pre-symptomatic changes in cerebrospinal fluid (CSF) Abeta42 levels CharacteristicsNLMCIADFTDTotal Number Age: Mean (y) Range (y) Gender: F M MMSE CDR sum of boxes Results Acknowledgements and Contact Discussion and Conclusions Hypometabolism in the FTD group exceeded that of the AD group in prefrontal cortex (p<0.0001), orbitofrontal gyrus (p<0.0001) and putamen (p<0.0001) when referenced to pons. ClassificationSensitivitySpecificityAccuracy AD vs. NL-NL97%100%98% FTD vs. NL-NL96%100%97% FTD vs. AD100%97%98% MCI-DeclCon vs. NL-NL95%100%96% NL-LowAB vs. NL-NL89% Table 2: Z-scores relative to NL-NL, referenced to pons Table 3: Classification Accuracies based upon ROI combinations Results of multiple-ROI classification are shown in Table 3 below. Classification accuracy for fifteen blinded NL, AD, and FTD subjects scored against these CV values was 94%. Combining these results with additional ROI information improved accuracy to 100%. Figure 1: Canonical Variates for 3 classes (NL, AD, FTD) NL AD FTD CV1 CV2 A subject’s (circles, triangles) higher placement along the vertical axis indicates greater similarity to the eigenimage patten relative to subjects at the lower end. Figure 3: CV2 Eigenimage (representative slices) The high classification accuracies achieved in our study of subjects from many different imaging sites using multiple scanner types were comparable to the results previously achieved using 7 academic sites (Mosconi et al, 2008). A progression in the severity of hypometabolism corresponding to sub-classes of clinical progression was demonstrated. Multivariate analyses applied on an ROI basis and on a voxel basis were instrumental in resolving complex, overlapping patterns. Incorporating ROI measures using our automated method enhanced subject classification by avoiding signal loss from spatial normalization and confirming subjects who deviated from typical group patterns. Though requiring further study, early Abeta42 changes appear to be associated with initial rCMglc decline. These results demonstrate the feasibility of achieving high diagnostic accuracies using rCMglc measurement with PET, and provide insight to the temporal emergence of CSF and rCMglc biomarker changes. Figure 2: CV1 Eigenimage (representative slices) FTD data was provided by the NINDS and Technische Universität München. Other data used were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database ( As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. ADNI investigators include (complete listing available at \ ADNI\Collaboration \ ADNI_ Manuscript_Citations.pdf). NPAIRS was developed at the University of Minnesota under the direction of Stephen Strother. ClassHIPMTLIPLPCCPFCMFGOFGPUTOCC NL-NL0.0 NL-LowAB NL-Decl MCI-NoDecl MCI-Decl MCI-DeclCon AD-VeryMild AD-MildMod FTD Regions shown: Hippocampus (HIP), whole medial temporal lobe (MTL), inferior parietal lobe (IPL), posterior cingulate/precuneus (PCC), prefrontal cortex (PFC), medial frontal gyrus (MFG), orbitofrontal gyrus (OFG), putamen (PUT), occipital lobe (OCC). As shown in Table 2, all classes of subjects showed hypometabolism compared to NL-NL. The extent and magnitude of decline increased in correspondence with severity of clinical decline. or to diagnosis of AD within 24 months; 33). NL were stratified into NL-NL (PIB 230, stable ADAS-11 and CDR-SB; 9), NL-LowAB (Abeta42<200, no decline; 18), and NL-Decl (worsened in ADAS-11 or CDR-SB within 18 months after baseline; 6). AD subjects were further stratified into AD-VeryMild (baseline CDR=0.5l; 14) and AD-MildMod (CDR>0.5; 20). MCI were stratified into MCI-NoDecl (stable ADAS-11 and CDR Sum of Box (SB) scores for 18 months after baseline; 6), MCI-Decl (worsened in ADAS-11 or CDR-SB; 19), and MCI-DeclCon (worsened in ADAS-11 and CDR-SB The first CV accounted for 71% of the variance between the three classes, and separated FTD subjects from NL and AD. The second CV, accounting for 29% of the variance, separated AD from NL. The eigenimage for CV2 exhibits hypometabolism in posterior cingulate/precuneus, parietal lobe, and temporal lobes characteristic of AD. The increase in cerebellum reflects its slower decline relative to global rCMglc in AD, evident due to the use of whole brain as reference for this analysis rather than pons. This difference contributes to the discrimination of disease classes.